| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/07/2026 | |
Jinchul Jeong
DFI | Director of Finance/CFO | - | - |
Greg Oehrtman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Bailey
BRD | Director/Board Member | 60 | 30/06/2026 |
| Director/Board Member | - | 01/07/2026 | |
Jinchul Jeong
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/01/23 | Issuer sale | Director | 1,10,043 | 0.3166% | ||
| 19/01/23 | Issuer sale | Director | 47,500 | 0.1366% | ||
| 19/01/23 | Issuer sale | Chief Operating Officer | 1,97,702 | 0.5687% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.20% | - | - | 52Cr | ||
| -1.00% | +0.41% | +41.86% | -5.58% | 7.87TCr | ||
| +2.08% | +29.11% | +708.13% | +102.59% | 7.94TCr | ||
| -1.21% | +0.77% | -10.63% | -30.06% | 5.95TCr | ||
| -1.80% | -2.29% | -13.07% | +28.02% | 4.65TCr | ||
| +1.18% | +3.03% | +9.11% | +169.01% | 4.66TCr | ||
| +0.55% | +5.61% | +67.76% | -10.75% | 3.36TCr | ||
| -0.44% | -1.13% | +51.71% | +110.88% | 2.51TCr | ||
| -0.10% | +3.21% | +4.89% | +155.64% | 2.21TCr | ||
| +0.05% | -2.42% | +57.59% | +97.38% | 1.53TCr | ||
| Average | -0.32% | +4.05% | +101.93% | +68.57% | 4.52TCr | |
| Weighted average by Cap. | -0.51% | +6.45% | +155.49% | +55.18% |
Employees
114
Sector
Pharmaceuticals
















